J. Scott Andrews
Endo Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Health Systems, Economic Evaluations, Quality of Life, Migraine and Headache Studies, Musculoskeletal pain and rehabilitation, Frailty in Older Adults
Most-Cited Works
- → Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup(2024)1,822 cited
- → Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials(2019)317 cited
- → Expectations and clinical meaningfulness of randomized controlled trials(2023)85 cited
- → Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1(2020)69 cited
- → Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS(2019)61 cited
- → Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries(2019)55 cited
- → One‐Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study(2018)50 cited
- → A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality(2024)50 cited
- → Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease(2015)49 cited
- → Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists(2016)48 cited